Kukje Pharma Co Ltd (002720) — Cash Flow Reinvestment Rate
Kukje Pharma Co Ltd (002720) has a Cash Flow Reinvestment Rate of 0.10x as of September 2025, reinvesting ₩474.52 Million (capex ₩474.52 Million ) from operating cash flow of ₩4.99 Billion. Check Kukje Pharma Co Ltd (002720) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Kukje Pharma Co Ltd Cash Flow Reinvestment Rate (2011–2024)
Historical reinvestment intensity for Kukje Pharma Co Ltd across 11 annual periods. Explore 002720 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Kukje Pharma Co Ltd (2011–2024)
Year-by-year capital reinvestment analysis for Kukje Pharma Co Ltd. For live market cap and broader valuation context, see 002720 company net worth.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.20x | ₩4.74 Billion | ₩3.94 Billion | ₩2.99 Billion | ▲ +248.0% |
| 2023 | 0.35x | ₩1.24 Billion | ₩3.58 Billion | ₩1.05 Billion | ▼ -13.7% |
| 2022 | 0.40x | ₩2.61 Billion | ₩6.50 Billion | ₩1.26 Billion | ▲ +18.2% |
| 2021 | 0.34x | ₩3.25 Billion | ₩9.60 Billion | ₩1.89 Billion | ▼ -87.5% |
| 2020 | 2.71x | ₩13.80 Billion | ₩5.10 Billion | ₩11.60 Billion | ▲ +39.2% |
| 2019 | 1.94x | ₩7.01 Billion | ₩3.60 Billion | ₩5.89 Billion | ▲ +510.6% |
| 2018 | 0.32x | ₩4.22 Billion | ₩13.25 Billion | ₩3.03 Billion | ▼ -94.4% |
| 2017 | 5.65x | ₩4.44 Billion | ₩786.10 Million | ₩2.61 Billion | ▲ +1090.8% |
| 2016 | 0.47x | ₩7.63 Billion | ₩16.10 Billion | ₩2.69 Billion | ▼ -52.8% |
| 2012 | 1.00x | ₩1.59 Billion | ₩1.58 Billion | ₩1.59 Billion | ▲ +1641.9% |
| 2011 | 0.06x | ₩1.00 Billion | ₩17.39 Billion | ₩1.00 Billion | — |